CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 263.9	$ 342.4
Short-term investments	165.3	157.9
Accounts receivable, net	269.8	243.9
Inventories	515.3	440.4
Other current assets	122.5	91.3
Total current assets	1,336.8	1,275.9
Property, plant and equipment, net	260.4	239.1
Goodwill	168.6	130.6
Intangibles, net and other long-term assets	195.7	162.8
Total assets	1,961.5	1,808.4
Current liabilities:
Current portion of long-term debt		20.1
Accounts payable	94.8	86.1
Customer advances	126.2	149.0
Other current liabilities	292.5	269.5
Total current liabilities	513.5	524.7
Long-term debt	480.5	391.6
Other long-term liabilities	227.6	199.0
Commitments and contingencies (Note 11)
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding
Common stock, $0.01 par value 260,000,000 shares authorized, 171,522,516 and 170,552,890 shares issued and 156,173,417 and 159,854,695 shares outstanding at September 30, 2017 and December 31, 2016, respectively	1.7	1.7
Treasury stock, at cost, 15,349,099 and 10,698,195 shares at September 30, 2017 and December 31, 2016, respectively	(380.9)	(249.3)
Accumulated other comprehensive income (loss)	10.5	(75.9)
Other shareholders' equity	1,100.5	1,009.9
Total shareholders' equity attributable to Bruker Corporation	731.8	686.4
Noncontrolling interest in consolidated subsidiaries	8.1	6.7
Total shareholders' equity	739.9	693.1
Total liabilities and shareholders' equity	$ 1,961.5	$ 1,808.4